索宝蛋白
(603231)
| 流通市值：21.43亿 | | | 总市值：38.62亿 |
| 流通股本：1.06亿 | | | 总股本：1.91亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 773,865,920.48 | 391,920,304.59 | 1,555,382,604.61 | 1,155,092,649.3 |
| 营业收入 | 773,865,920.48 | 391,920,304.59 | 1,555,382,604.61 | 1,155,092,649.3 |
| 二、营业总成本 | 666,429,394.26 | 340,412,070.35 | 1,435,473,164.94 | 1,073,407,161.58 |
| 营业成本 | 628,831,290.74 | 323,557,282.9 | 1,368,635,123.49 | 1,026,920,691.28 |
| 税金及附加 | 4,679,314.76 | 1,937,814.31 | 7,327,970.74 | 5,314,028.72 |
| 销售费用 | 11,442,949.61 | 5,352,784.48 | 22,919,109.29 | 14,291,897.46 |
| 管理费用 | 22,168,299.07 | 10,224,417.29 | 38,877,491.6 | 26,420,500.42 |
| 研发费用 | 3,253,258.06 | 1,405,431.57 | 10,410,192.23 | 8,089,606.75 |
| 财务费用 | -3,945,717.98 | -2,065,660.2 | -12,696,722.41 | -7,629,563.05 |
| 其中:利息费用 | 77,609.38 | 61,431.26 | 140,609.19 | 132,091.56 |
| 其中:利息收入 | 1,005,109.95 | 401,664.07 | 6,733,649.72 | 5,813,425.7 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 2,926,444.79 | 1,392,917.74 | 6,201,917.5 | 2,069,361.07 |
| 加:投资收益 | 702,493.6 | 457,457.05 | 5,341,043.26 | 7,085,298.38 |
| 资产处置收益 | -499,658.78 | -15,384.63 | -29,666.68 | 91,590.42 |
| 资产减值损失(新) | 16,626.41 | - | -4,052,226.63 | - |
| 信用减值损失(新) | -242,456.59 | -589,164.59 | 4,732,646.1 | 4,858,715.28 |
| 其他收益 | 6,506,503.89 | 733,900.98 | 16,194,450.53 | 14,966,791.57 |
| 四、营业利润 | 116,846,479.54 | 53,487,960.79 | 148,297,603.75 | 110,757,244.44 |
| 加:营业外收入 | 215,708.95 | 176,541.05 | 356,705.75 | 273,986.21 |
| 减:营业外支出 | 393,506.69 | 90,732.42 | 4,571,806.81 | 1,939,049.51 |
| 五、利润总额 | 116,668,681.8 | 53,573,769.42 | 144,082,502.69 | 109,092,181.14 |
| 减:所得税费用 | 19,236,287.73 | 9,097,677.01 | 22,901,768.94 | 17,411,650.06 |
| 六、净利润 | 97,432,394.07 | 44,476,092.41 | 121,180,733.75 | 91,680,531.08 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 97,432,394.07 | 44,476,092.41 | 121,180,733.75 | 91,680,531.08 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 97,432,394.07 | 44,476,092.41 | 121,180,733.75 | 91,680,531.08 |
| 扣除非经常损益后的净利润 | 93,203,836.86 | 41,860,638.1 | 109,594,020.11 | 81,335,479.43 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.51 | 0.23 | 0.63 | 0.48 |
| (二)稀释每股收益 | 0.51 | 0.23 | 0.63 | 0.48 |
| 八、其他综合收益 | 31,626.37 | 3,893.03 | -7,910.06 | - |
| 归属于母公司股东的其他综合收益 | 31,626.37 | 3,893.03 | -7,910.06 | - |
| 九、综合收益总额 | 97,464,020.44 | 44,479,985.44 | 121,172,823.69 | 91,680,531.08 |
| 归属于母公司股东的综合收益总额 | 97,464,020.44 | 44,479,985.44 | 121,172,823.69 | 91,680,531.08 |
| 公告日期 | 2025-08-28 | 2025-04-25 | 2025-04-25 | 2024-10-26 |
| 审计意见(境内) | | | 标准无保留意见 | |